NeuroStar uses transcranial magnetic stimulation (TMS) to target key areas of the brain that are underactive in people with depression. It is not ECT (electroconvulsive therapy).
While the exact cause of depression is not known, the leading scientific theory is that it is caused by an imbalance of the brain’s neurotransmitters, which are chemical messengers that send signals between brain cells.
What is NeuroStar Advanced Therapy (TMS)?
During a NeuroStar treatment session, a magnet similar in strength to that used in a magnetic resonance imaging (MRI) machine is used to stimulate nerve cells in the area of the brain thought to control mood. These magnetic pulses may have a positive effect on the brain’s neurotransmitter levels, making long-term remission possible.
Treatment with NeuroStar Advanced Therapy is easy:
- Therapy sessions are conducted in your doctor’s office
- You can return to normal activities right away
- You are awake during treatment
- There are no negative effects on memory or sleep
- It’s covered by most health insurance plans, including Medicare and Tricare
With more than one million treatments performed, this novel treatment approach to achieving remission is bringing new hope to people every day.
What happens during a typical NeuroStar TMS treatment session?
Most Insurances Accepted
Fill out the form below to get in touch with us for more details and schedule an appointment
NeuroStar TMS Therapy is only available by prescription. A doctor can help decide if NeuroStar TMS Therapy is right for you.
Important Safety Information
The most common side effect is pain or discomfort at or near the treatment site. These events are transient; they occur during the TMS treatment course and do not occur for most patients after the first week of treatment. There is a rare risk of seizure associated with the use of NeuroStar TMS (<0.1% per patient).
NeuroStar TMS Therapy should not be used with patients who have non-removable conductive metal in or near the head. NeuroStar TMS Therapy has not been studied in patients who have not received prior antidepressant treatment.
